Biochanin A suppresses ferroptosis after traumatic brain injury via the Nrf2/HO-1 signaling pathway
Abstract
Traumatic brain injury can induce ferroptosis, which plays an important role in TBI progression. Therapies targeting ferroptosis are beneficial for TBI recovery. Biochanin A can be isolated from Huangqi, which has been shown to exert anti-inflammatory and antioxidant effects. Nevertheless, the underlying mechanism of BCA on secondary injury after TBI remain unclear. This study aimed to investigate the mechanism by which BCA regulates ferroptosis after TBI. The mouse TBI model and HT-22 cells were utilized to study the protective effect of BCA on the injury induced by ferroptosis after TBI. Through in vivo experiments, a mouse TBI model was established to determine that BCA could reduce post-TBI injury and exert neuroprotective effects as determined by the Modified Neurological Severity scale, brain water content, Nissl staining, hematoxylin-eosin staining, TUNEL staining. BCA was proven to be capable of inhibiting the changes in post-TBI ferroptosis-related proteins, activating the Nrf2/HO-1 signaling pathway, and reducing oxidative stress, as confirmed by Western blotting. In vitro, erastin-induced ferroptosis in HT-22 cells was attenuated by BCA, as shown increased cell viability, reduced reactive oxygen species and and lipid peroxidation, and restored antioxidant levels. BCA suppressed protein levels of multiple ferroptosis-associated markers in this cell model. In conclusion, BCA had a neuroprotective effect after TBI by inhibiting ferroptosis via activating the Nrf2/HO-1 pathway. These findings may provide potential therapeutic strategies for TBI.
Related
- HnRNPK suppresses macrophage-driven inflammation in autoimmune myocarditis by restraining NCF1-dependent oxidized phospholipid signaling and ferroptosis-related changes.
- Terahertz Photons Ameliorate Traumatic Brain Injury and Reduce Neuroinflammation via the Cyclic Adenosine Monophosphate Signaling Pathway.
- Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction
- Targeting Caveolin-1 Alleviated Diabetic Retinopathy Injury through Protecting Müller Cells from Ferroptosis via the xCT/GPX4 Signaling Pathway
- Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI‐CKD
BibTeX
@article{hu2026biochanin,
title = {{Biochanin A suppresses ferroptosis after traumatic brain injury via the Nrf2/HO-1 signaling pathway}},
author = {Yuehuan Hu and Mingxia Zhang and Hui Zhao and Yao Ruan and Tian Liu},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74944-z},
url = {https://www.nature.com/articles/s41598-026-74944-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Biochanin A suppresses ferroptosis after traumatic brain injury via the Nrf2/HO-1 signaling pathway
AU - Yuehuan Hu
AU - Mingxia Zhang
AU - Hui Zhao
AU - Yao Ruan
AU - Tian Liu
PY - 2026
DA - 2026/10/15
JO - Scientific Reports
DO - 10.1038/s41598-026-74944-z
UR - https://www.nature.com/articles/s41598-026-74944-z
AB - Traumatic brain injury can induce ferroptosis, which plays an important role in TBI progression. Therapies targeting ferroptosis are beneficial for TBI recovery. Biochanin A can be isolated from Huangqi, which has been shown to exert anti-inflammatory and antioxidant effects. Nevertheless, the underlying mechanism of BCA on secondary injury after TBI remain unclear. This study aimed to investigate the mechanism by which BCA regulates ferroptosis after TBI. The mouse TBI model and HT-22 cells were utilized to study the protective effect of BCA on the injury induced by ferroptosis after TBI. Through in vivo experiments, a mouse TBI model was established to determine that BCA could reduce post-TBI injury and exert neuroprotective effects as determined by the Modified Neurological Severity scale, brain water content, Nissl staining, hematoxylin-eosin staining, TUNEL staining. BCA was proven to be capable of inhibiting the changes in post-TBI ferroptosis-related proteins, activating the Nrf2/HO-1 signaling pathway, and reducing oxidative stress, as confirmed by Western blotting. In vitro, erastin-induced ferroptosis in HT-22 cells was attenuated by BCA, as shown increased cell viability, reduced reactive oxygen species and and lipid peroxidation, and restored antioxidant levels. BCA suppressed protein levels of multiple ferroptosis-associated markers in this cell model. In conclusion, BCA had a neuroprotective effect after TBI by inhibiting ferroptosis via activating the Nrf2/HO-1 pathway. These findings may provide potential therapeutic strategies for TBI.
SN - 2045-2322
ER -